XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a large decline in short interest during the month of May. As of May 29th, there was short interest totaling 84 shares, a decline of 72.7% from the May 14th total of 308 shares. Based on an average daily trading volume, of 1,762 shares, the days-to-cover ratio is currently 0.0 days.
XOMA Price Performance
Shares of NASDAQ:XOMAP traded down $0.04 during midday trading on Friday, reaching $25.47. The company had a trading volume of 1,001 shares, compared to its average volume of 2,009. The company’s 50 day moving average price is $25.73 and its 200 day moving average price is $26.11. XOMA has a 52-week low of $25.14 and a 52-week high of $30.00.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Recommended Stories
- Five stocks we like better than XOMA
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
